article thumbnail

Dyadic International Extends Collaboration With The Scripps Research Institute on C1 Genome

Green Car Congress

Dyadic International, Inc., a biotechnology company developing enzymes for use in the production of cellulosic ethanol, has extended its collaboration with The Scripps Research Institute by entering into an agreement with Scripps to re-annotate the genome of Dyadic’s patented and proprietary Chrysosporium lucknowense fungus, known as C1.

C1 170
article thumbnail

Dyadic International expands license agreement With Abengoa

Green Car Congress

has agreed to pay Dyadic International, Inc., has agreed to pay Dyadic International, Inc., The amended license agreement expands the territories to worldwide rights and provides Abengoa with the ability to produce, use and sell C1 enzymes in first as well as second generation biofuels and other bio-based processes.

C1 210
article thumbnail

Dyadic and CIMV to collaborate on 2nd generation biofuel and bio-based chemical technologies

Green Car Congress

Enzyme company Dyadic International, Inc. signed a collaboration agreement with Compagnie Industrielle de la Matière Végétale ( CIMV ), a developer of processes for the production of biofuels and bio-based chemicals, to commercialize second-generation biofuel and bio-based chemical technology.

C1 218
article thumbnail

DOE awards $35M to 15 projects in ARPA-E ECOSynBio program to reduce carbon footprint of biofuel production

Green Car Congress

At commercial scale, the inputs to the proposed “carbon refinery” process are carbon-free renewable energy, water, and CO 2. The CO 2 released in the upgrading process is recycled internally to produce more acetate. The system’s commercial competitiveness is currently limited by the rate of CO 2 fixation in the first stage.

Carbon 303